Clozapine, a novel antipsychotic agent, is an alternative to standard
neuroleptic therapy for psychotic disorders. Some advantages of clozap
ine over neuroleptics are that it may be a more effective antipsychoti
c in treatment resistant patients and has a lower incidence of extrapy
ramidal side effects. However, seizures associated with clozapine trea
tment occur at a rate of about three percent. Factors which seem to in
crease the likelihood of seizures include high doses of clozapine, rap
id dose titration, the concurrent use of other epileptogenic agents an
d a previous history of neurological abnormalities. A strategy that ha
s been proposed to reduce the occurrence of seizures is the addition o
f an anticonvulsant agent. At present, little rigorous scientific evid
ence exists to establish the effectiveness of this strategy or the cho
ice of an anticonvulsant. However, based on what evidence there is and
the side effect profiles of the various anticonvulsants, the authors
propose the use of valproic acid for the prophylaxis and management of
clozapine related seizures.